Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11752206 Herpes simplex virus vaccine

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 15, 2018
Date of Patent
September 12, 2023
Patent Application Number
16494130
Patent Citations
‌
US Patent 9464124 Engineered nucleic acids and methods of use thereof
‌
US Patent 9868691 Compounds and compositions for intracellular delivery of therapeutic agents
‌
US Patent 9868692 Compounds and compositions for intracellular delivery of therapeutic agents
‌
US Patent 9872900 Nucleic acid vaccines
‌
US Patent 10022435 Nucleic acid vaccines
‌
US Patent 10023626 Polynucleotides encoding immune modulating polypeptides
‌
US Patent 10064934 Combination PIV3/hMPV RNA vaccines
‌
US Patent 10064935 Human cytomegalovirus RNA vaccines
‌
US Patent 10124055 Zika virus RNA vaccines
‌
US Patent 10207010 Compositions and methods for delivery of agents
•••
Patent Citations Received
‌
US Patent 11905525 Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
0
Patent Inventor Names
Dai Wang
Giuseppe Ciaramella
Shinu John
Danilo R. Casimiro
Andrew J. Bett
Lan Zhang
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11752206
Patent Primary Examiner
‌
Rachel B Gill
CPC Code
‌
C07K 2319/02
‌
C07K 2319/40
‌
C12N 7/00
‌
C12N 2710/16622
‌
C12N 2710/16634
‌
Y02A 50/30
‌
A61K 39/245
‌
A61K 9/0019
‌
A61K 9/5123
‌
A61K 9/5146
•••

Find more entities like US Patent 11752206 Herpes simplex virus vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo